Hillsdale Investment Management Inc. Grows Stock Position in Nutrien Ltd. $NTR

Hillsdale Investment Management Inc. lifted its holdings in Nutrien Ltd. (NYSE:NTRFree Report) by 219,825.0% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 131,955 shares of the company’s stock after purchasing an additional 131,895 shares during the period. Hillsdale Investment Management Inc.’s holdings in Nutrien were worth $7,747,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. AMG National Trust Bank increased its holdings in Nutrien by 4.0% during the third quarter. AMG National Trust Bank now owns 4,986 shares of the company’s stock valued at $293,000 after buying an additional 193 shares during the last quarter. Beverly Hills Private Wealth LLC bought a new stake in shares of Nutrien during the 3rd quarter valued at $231,000. Cumberland Partners Ltd bought a new stake in shares of Nutrien during the 3rd quarter valued at $4,582,000. Colrain Capital LLC increased its stake in shares of Nutrien by 35.6% in the 3rd quarter. Colrain Capital LLC now owns 128,150 shares of the company’s stock worth $7,595,000 after purchasing an additional 33,650 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in Nutrien by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 21,983,443 shares of the company’s stock worth $1,291,022,000 after purchasing an additional 80,135 shares during the period. 63.10% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on NTR shares. Morgan Stanley raised Nutrien from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $70.00 to $77.00 in a report on Wednesday, January 14th. Barclays raised their target price on shares of Nutrien from $64.00 to $70.00 and gave the stock an “equal weight” rating in a research note on Wednesday. Wells Fargo & Company upped their price target on shares of Nutrien from $64.00 to $77.00 and gave the stock an “equal weight” rating in a research report on Friday. Weiss Ratings restated a “hold (c)” rating on shares of Nutrien in a research report on Monday, December 29th. Finally, Oppenheimer restated an “outperform” rating on shares of Nutrien in a research note on Tuesday, January 27th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $70.11.

View Our Latest Report on NTR

Key Stories Impacting Nutrien

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Multiple broker upgrades and higher price targets — BMO raised its target to $85 (outperform), JPMorgan to $78 (overweight), Wells Fargo to $77 (equal weight) and Raymond James to $74, signaling analyst confidence in Nutrien’s outlook and suggesting meaningful upside from recent levels. BayStreet.CA Benzinga
  • Positive Sentiment: Shareholder returns: Nutrien raised its quarterly dividend (to $0.55) and announced a new buyback program — a direct positive for investors seeking yield and capital return. TipRanks
  • Positive Sentiment: Favorable commodity outlook: Management expects stronger global potash demand in 2026 despite difficult farm economics — a revenue/volume tailwind for Nutrien’s fertilizer segment. Reuters
  • Neutral Sentiment: Earnings materials available — full Q4 2025 call transcript and presentation have been published for investor review; useful for drilling into segment-level detail but not a directional catalyst by itself. Seeking Alpha Yahoo Finance
  • Neutral Sentiment: Some analysts remain cautious: Bank of America raised its target to $71 but kept a neutral rating (minimal implied upside). That tempers the bullish momentum from higher targets. Benzinga
  • Negative Sentiment: Operational results missed consensus: Q4 EPS came in at $0.83 vs. $0.87 expected and revenue of ~$5.12B was slightly below estimates — the earnings miss is the primary near-term negative pressure on the share price. Zacks
  • Negative Sentiment: Mixed analyst views persist — UBS assigned a “hold,” which indicates some investors and brokers are reserving judgment despite the positive catalysts. Globe & Mail

Nutrien Trading Down 0.8%

Nutrien stock opened at $71.19 on Friday. Nutrien Ltd. has a 1 year low of $45.78 and a 1 year high of $73.55. The firm’s 50 day moving average price is $66.23 and its 200-day moving average price is $60.66. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.41 and a quick ratio of 0.89. The stock has a market cap of $34.27 billion, a P/E ratio of 15.28 and a beta of 0.73.

Nutrien (NYSE:NTRGet Free Report) last issued its earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.04). The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a return on equity of 8.46% and a net margin of 8.43%.Nutrien’s revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.31 EPS. On average, equities analysts predict that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be issued a $0.55 dividend. This represents a $2.20 annualized dividend and a dividend yield of 3.1%. This is a positive change from Nutrien’s previous quarterly dividend of $0.55. The ex-dividend date of this dividend is Tuesday, March 31st. Nutrien’s payout ratio is presently 58.76%.

Nutrien Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Further Reading

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.